Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-051159
Filing Date
2009-03-12
Accepted
2009-03-11 20:59:50
Documents
10
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 689205
2 AMENDMENT OF EMPLOYMENT AGREEMENT - PETER M. STRUMPH dex1018.htm EX-10.18 7501
3 AMENDMENT TO OFFER LETTER - HSIAO D. LIEU dex1019.htm EX-10.19 7498
4 AMENDMENT TO OFFER LETTER - JANE MOFFITT dex1020.htm EX-10.20 7482
5 CONSENT OF HAYS & COMPANY, LLP dex231.htm EX-23.1 1573
6 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 8166
7 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 8175
8 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 3560
9 CERTIFICATION PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 3534
10 GRAPHIC g74638g72q09.jpg GRAPHIC 3209
  Complete submission text file 0001193125-09-051159.txt   742775
Mailing Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104
Business Address 115 SANSOME STREET, SUITE 310 SAN FRANCISCO CA 94104 (415) 875-7880
Nile Therapeutics, Inc. (Filer) CIK: 0001133869 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34058 | Film No.: 09673943
SIC: 2834 Pharmaceutical Preparations